XML 104 R60.htm IDEA: XBRL DOCUMENT v3.24.1
STOCKHOLDERS’ EQUITY - Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2020
Number of Shares        
Outstanding, beginning balance (in shares) 781,092 816,717 1,162,505  
Granted (in shares) 0 0 0  
Exercised (in shares) (98,952) (35,625) (329,878)  
Canceled (in shares) (30,871) 0 (15,910)  
Outstanding, ending balance (in shares) 651,269 781,092 816,717 1,162,505
Weighted- Average Exercise Price        
Outstanding, beginning balance (in dollars per share) $ 7.46 $ 7.42 $ 7.51  
Granted (in dollars per share) 0 0 0  
Exercised (in dollars per share) 7.44 6.68 7.63  
Canceled (in dollars per share) 9.49 0 9.41  
Outstanding, ending balance (in dollars per share) $ 7.37 $ 7.46 $ 7.42 $ 7.51
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]        
Vested and expected to vest (in shares) 651,269      
Exercisable (in shares) 647,884      
Vested and expected to vest, weighted-average exercise price (in dollars per share) $ 7.37      
Exercisable, weighted-average exercise price (in dollars per share) $ 7.35      
Outstanding, weighted-average remaining contractual terms (in years) 3 years 7 months 6 days 3 years 8 months 12 days 5 years 9 months 18 days 6 years 1 month 6 days
Vested and expected to vest, weighted-average remaining contractual term (in years) 3 years 7 months 6 days      
Exercisable, weighted-average remaining contractual term (in years) 3 years 7 months 6 days      
Outstanding, aggregate intrinsic value $ 2,185 $ 1,512 $ 9,046 $ 6,081
Exercised, aggregate intrinsic value 338 $ 279 $ 2,670  
Vested and expected to vest, aggregate intrinsic value 2,185      
Exercisable, aggregate intrinsic value $ 2,181